ESC 365 - Hybrid coronary revascularization versus PCI for the treatment of high-risk patients with multivessel coronary artery disease: 2-year follow-up results from two institutions

ESC2025 Premium Access

Hybrid coronary revascularization versus PCI for the treatment of high-risk patients with multivessel coronary artery disease: 2-year follow-up results from two institutions

Session: Revascularisation in coronary artery disease

Topic: Revascularisation

Speaker: Professor H. Yan (Wuhan, CN)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Professor Hua Yan

Wuhan Asia Heart Hospital, Wuhan (China)

0 follower

7 more presentations in this session

Associations between dual trajectories of body mass index and waist-to-height ratio over a decade and incident coronary heart disease

Speaker: Miss C. Huang (London, GB)

The EAPCI device success algorithm in the PIONEER IV trial: insights with angiography-derived FFR

Speaker: Doctor A. Oshima (Galway, IE)

Invasive vs. conservative strategies in older patients with non-st-segment elevation myocardial infarction: an updated systematic review and meta-analysis

Speaker: Doctor L. Lucena (Florianopolis, BR)

Impact of strut thickness on vessel responses after polymer-free biolimus A9-coated stents: both optical coherence tomographic and coronary angioscopic evaluations

Speaker: Doctor M. Kusuda (Amagasaki, JP)

The association of aging and the efficacy of PCI in stable coronary artery disease. A secondary analysis of ORBITA-2.

Speaker: Doctor F. Simader (London, GB)

Access the full session

Revascularisation in coronary artery disease

Speakers: Professor H. Yan, Miss C. Huang, Doctor A. Oshima, Doctor L. Lucena, Doctor M. Kusuda...

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources